{"slug":"neuroblastoma","tag":"neuroblastoma","variants":["neuroblastoma"],"description":"No description yet","count":6,"kinds":{"person":6},"related":[{"slug":"paediatric","tag":"paediatric","shared":4},{"slug":"clinician-scientist","tag":"clinician-scientist","shared":2},{"slug":"leadership","tag":"leadership","shared":2},{"slug":"paediatric-oncology","tag":"paediatric oncology","shared":2},{"slug":"alk","tag":"alk","shared":1},{"slug":"cooperative-group","tag":"cooperative-group","shared":1},{"slug":"genomics","tag":"genomics","shared":1},{"slug":"immunotherapy","tag":"immunotherapy","shared":1}],"records":[{"id":"louis-chesler","kind":"person","name":"Louis Chesler","route":"/people/louis-chesler/","tldr":"Paediatric oncologist and neuroblastoma researcher who leads Children's Cancer Institute in Sydney, Australia's dedicated childhood cancer research institute."},{"id":"meredith-irwin","kind":"person","name":"Meredith Irwin","route":"/people/meredith-irwin/","tldr":"Paediatric oncologist and neuroblastoma researcher who serves as Paediatrician-in-Chief at SickKids in Toronto."},{"id":"ruth-ladenstein","kind":"person","name":"Ruth Ladenstein","route":"/people/ruth-ladenstein/","tldr":"Chaired the SIOPEN HR-NBL1 trial, the largest neuroblastoma trial ever, which set European standards for high-risk disease."},{"id":"john-maris","kind":"person","name":"John M. Maris","route":"/people/john-maris/","tldr":"Neuroblastoma geneticist whose lab found the ALK mutations and immunotherapy targets now in paediatric trials."},{"id":"yael-mosse","kind":"person","name":"Yael P. Mossé","route":"/people/yael-mosse/","tldr":"Discovered ALK mutations in neuroblastoma and led the trials bringing crizotinib and lorlatinib to children."},{"id":"nai-kong-cheung","kind":"person","name":"Nai-Kong V. Cheung","route":"/people/nai-kong-cheung/","tldr":"Developed the anti-GD2 antibodies 3F8 and naxitamab that treat relapsed neuroblastoma."}]}